The LOXHD1 gene is responsible for encoding a protein that plays a crucial role in the normal functioning of the inner ear, particularly in the hair cells that are essential for hearing. Mutations in the LOXHD1 gene can lead to a form of hearing loss known as deafness, autosomal recessive type 77 (DFNB77). This condition is characterized by prelingual, non-syndromic sensorineural hearing loss, which means it occurs before speech development and is not associated with other symptoms. It is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this specific type of genetic hearing loss, a genetic test targeting the LOXHD1 gene can be conducted. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The test involves analyzing the patient's DNA, extracted from a blood sample, to look for mutations in the LOXHD1 gene that are known to cause DFNB77. This test is crucial for early diagnosis and management of the condition, potentially allowing for interventions that could improve the quality of life for those affected.
The cost of the LOXHD1 gene deafness autosomal recessive type 77 genetic test at DNA Labs UAE is 4400 AED. This cost covers the process of collecting the sample, the genetic analysis, and the provision of a detailed report explaining the test results. For families with a history of this condition or for newborns showing signs of hearing loss, this test provides a valuable tool for confirming the diagnosis and guiding future care and treatment options.
The TPRN Gene Deafness Autosomal Recessive Type 79 Genetic Test is a specific diagnostic procedure aimed at identifying mutations in the TPRN gene, which are linked to a form of hereditary hearing loss. This condition, known as Autosomal Recessive Non-Syndromic Hearing Loss (ARNSHL) Type 79, is characterized by its genetic transmission mode, where an individual must inherit two copies of the mutated gene (one from each parent) to manifest the disorder. The TPRN gene plays a crucial role in the development and function of the inner ear, and mutations can lead to significant hearing impairment from birth or early childhood.
The test is available at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities and adherence to international standards of accuracy and confidentiality. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis involved in detecting the specific genetic alterations associated with this form of deafness. By opting for this test, individuals with a family history of hearing loss can gain valuable insights into their genetic status, enabling informed decisions about family planning and access to early intervention services. Moreover, the results can guide healthcare professionals in tailoring personalized management and treatment plans for affected individuals, potentially improving their quality of life.
The TBC1D24 gene is associated with a form of deafness known as Autosomal Recessive Deafness Type 86 (DFNB86). This condition is characterized by a genetic mutation in the TBC1D24 gene, leading to hearing impairment. The inheritance pattern of this condition is autosomal recessive, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
To diagnose this specific type of genetic deafness, a specialized genetic test is available at DNA Labs UAE. This test involves analyzing the DNA to identify mutations in the TBC1D24 gene that are responsible for the condition. It is a crucial step for families with a history of hearing loss or for individuals who have early signs of hearing impairment, providing them with essential information for making informed decisions about their health or family planning.
The cost of the TBC1D24 Gene Deafness Autosomal Recessive Type 86 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted with high precision and accuracy, ensuring reliable results for those being tested. After the test, genetic counseling may be recommended to discuss the results and understand the implications for the individual and their family.
The KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the KARS1 gene, which are linked to Autosomal Recessive Deafness 89 (DFNB89). This condition is characterized by the impairment of hearing that results from genetic variations inherited from both parents. The test is particularly crucial for families with a history of hearing loss, as it can provide valuable information for early intervention and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to detect any abnormalities in the KARS1 gene. The process is meticulous and requires advanced technological tools to ensure accuracy and reliability in the results. Given the complexity and the specialized nature of the test, the cost is set at 4400 AED. This investment covers the comprehensive analysis and the expertise required to interpret the results accurately.
Early detection through the KARS1 Gene Deafness Autosomal Recessive Type 89 Genetic Test can be pivotal for affected individuals and their families. It not only aids in understanding the risk of transmitting the condition to future generations but also opens up avenues for early interventions that can significantly improve the quality of life for those diagnosed with this type of hearing loss.
The OTOF Gene Deafness Autosomal Recessive Type 9 Genetic Test is a specialized diagnostic assessment designed to identify mutations in the OTOF gene, which are linked to a specific form of genetic hearing loss known as autosomal recessive nonsyndromic hearing loss (ARNSHL) type 9. This condition is characterized by the absence or severe impairment of hearing from birth or early childhood, which results from mutations in the OTOF gene that impact the function of inner ear hair cells, crucial for the conversion of sound vibrations into neural signals.
Administered at DNA Labs UAE, a leading facility in genetic diagnostics, this test is essential for families with a history of hearing loss, providing them with vital information regarding the genetic underpinnings of their condition. By analyzing a sample of the patient's DNA, the test seeks to identify specific mutations in the OTOF gene that are responsible for this type of deafness, thereby facilitating early diagnosis and intervention strategies.
The cost of the OTOF Gene Deafness Autosomal Recessive Type 9 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the intricate processes involved in genetic analysis and the specialized expertise required to interpret the results accurately. Early detection through this test can significantly impact the management and treatment of the condition, offering affected individuals and their families a clearer understanding of the condition and how to address it effectively.
The CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test is a specialized diagnostic assessment aimed at detecting mutations in the CABP2 gene, which are known to cause Autosomal Recessive Deafness Type 93 (DFNB93), a form of non-syndromic hearing loss. This genetic condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The test is crucial for families with a history of hearing loss, as early identification can facilitate timely intervention and support.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the CABP2 gene. The outcome of this test can provide essential information for affected families, including guidance on managing the condition and understanding the risk for future children.
The cost of the CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the comprehensive nature of the test, from sample collection and genetic sequencing to the expert analysis and reporting of results. While the price may seem significant, the value of the insights gained for affected individuals and their families is immeasurable, offering a clearer path to coping with the condition and making informed decisions about their health and lifestyle.
The "FGF3 Gene Deafness Congenital with Inner Ear Agenesis, Microtia, and Microdontia Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the FGF3 gene. These mutations are associated with a rare congenital condition characterized by deafness due to inner ear agenesis (absence or malformation of the inner ear), microtia (underdevelopment of the external ear), and microdontia (abnormally small teeth). The condition is genetic, highlighting the importance of this test for families with a history of these symptoms, providing them with crucial information for managing and understanding their health.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. This sample is then analyzed in the laboratory to detect any abnormalities or mutations in the FGF3 gene that could indicate the presence of this condition. Given the complexity and the specialized nature of the test, it is conducted in the advanced facilities of DNA Labs UAE, ensuring accuracy and reliability in the results.
For individuals or families facing the symptoms associated with this genetic condition, the test offers not just a diagnosis but also a pathway to better understand the condition, enabling informed decisions about treatment options and management strategies. It is an essential tool in the arsenal of genetic testing for congenital deafness and related syndromes.
The BCAP31 gene, located on the X chromosome, plays a crucial role in various cellular processes, including apoptosis and the transport of proteins. Mutations in this gene are associated with a rare genetic condition that manifests as a combination of symptoms, including deafness, dystonia (a movement disorder), and cerebral hypomyelination, which refers to a reduced amount of myelin in the brain. Myelin is essential for the proper functioning of the nervous system as it facilitates the rapid transmission of electrical signals along nerve cells.
The BCAP31 Gene Deafness Dystonia and Cerebral Hypomyelination X-Linked Genetic Test is a specialized diagnostic tool designed to detect mutations in the BCAP31 gene. This test is crucial for confirming the diagnosis of the condition, understanding its severity, and guiding treatment and management decisions. Early diagnosis through genetic testing can significantly impact the management of the symptoms and improve the quality of life for affected individuals.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory facility, equipped with advanced genetic testing technologies to ensure accurate and reliable results. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the BCAP31 gene. The results of the test provide valuable information for affected individuals, their families, and healthcare providers, enabling them to make informed decisions regarding treatment and care.
The "MT-RNR1 Gene Deafness Nonsyndromic Sensorineural Mitochondrial Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the MT-RNR1 gene, which are associated with nonsyndromic sensorineural deafness. This type of hearing loss is characterized by the impairment of sound transmission from the inner ear to the brain, without other associated systemic findings. The condition is mitochondrial in nature, meaning it is inherited through mutations passed down from the mother, as mitochondria are maternally inherited.
The test is crucial for individuals with a family history of hearing loss or those showing symptoms of sensorineural deafness, as early detection can significantly impact management and treatment options. By analyzing the genetic material for specific mutations in the MT-RNR1 gene, healthcare professionals can provide personalized advice, potential interventions, and family planning guidance to those affected.
DNA Labs UAE offers this genetic testing service at a cost of 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in their state-of-the-art laboratory facilities. The results not only help in confirming the diagnosis but also in understanding the inheritance pattern, which is crucial for affected families. This test represents a blend of advanced genetic science and clinical medicine, aimed at improving the quality of life for individuals with hereditary hearing loss conditions.
The PRPS1 gene, associated with Deafness X-Linked Type 1, plays a crucial role in purine metabolism, which is essential for the normal functioning of cells, including those in the auditory system. Mutations in the PRPS1 gene can lead to X-linked deafness, a condition that affects males predominantly and can vary in severity from mild to profound hearing loss. Genetic testing for mutations in the PRPS1 gene is a valuable tool in diagnosing this form of deafness, enabling early intervention and management strategies to improve quality of life for those affected.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the PRPS1 gene. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of genetic alterations in the PRPS1 gene. This test is critical for families with a history of X-linked deafness, providing them with crucial information for genetic counseling, family planning, and exploring treatment options.
